Sale!

S6 Kinase Substrate Amide Conjugated to Biotin

Original price was: $139.23.Current price is: $34.81.

SKU: PW14836851862 Category:

Description

S6 Kinase Substrate Amide Conjugated to Biotin

Catalog number: B2011312
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: 1538.9
Supplied as: Lyophilized
Applications: molecular tool for various biochemical applications
Storage: -20 C
Keywords: S6 Kinase Substrate (229-239), Amide, Biotinylated
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Arthur JS. MSK activation and physiological roles Front Biosci. 2008 May 1;13:5866-79.
  • Joseph CK, Byun HS, Bittman R, Kolesnick RN. Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed J Biol Chem. 1993 Sep 25;268(27):20002-6.
  • Hioki T, Tokuda H, Nakashima D, Fujita K, Kawabata T, Sakai G, Kim W, Tachi J, Tanabe K, Matsushima-Nishiwaki R, Otsuka T, Iida H, Kozawa O. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase Cell Biochem Funct. 2021 Jan;39(1):88-97.
  • Zhang Z, Cohen DM. Urea activates ribosomal S6 kinase (RSK) in a MEK-dependent fashion in renal mIMCD3 cells Am J Physiol. 1998 Jan;274(1):F73-8.
  • Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Mario G, BenYounes A, Bnit P, Rustin P, Maiuri MC, Kroemer G. BH3 mimetics activate multiple pro-autophagic pathways Oncogene. 2011 Sep 15;30(37):3918-29.
  • Toms-Zuber M, Mary JL, Lesslauer W. Control sites of ribosomal S6 kinase B and persistent activation through tumor necrosis factor J Biol Chem. 2000 Aug 4;275(31):23549-58.
  • Ly C, Arechiga AF, Melo JV, Walsh CM, Ong ST. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin Cancer Res. 2003 Sep 15;63(18):5716-22.
  • Brindley DN, Wang CN, Mei J, Xu J, Hanna AN. Tumor necrosis factor-alpha and ceramides in insulin resistance Lipids. 1999;34 Suppl:S85-8.
  • Fettiplace MR, Kowal K, Ripper R, Young A, Lis K, Rubinstein I, Bonini M, Minshall R, Weinberg G. Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion Anesthesiology. 2016 Feb;124(2):428-42.